Cardiacbooster develops an effective, low profile cardiac assist device. The envisioned product concept is a catheter-based device which supports the heart’s pump action inside the left ventricle in sync with the cardiac rhythm. This concept is expected to support heart function by augmenting the stroke volume, thereby helping to maintain and restore the natural pulsatile circulatory flow pattern. This way the device prevents a downward spiral, where more and more parts of the heart decease.
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial disease.